RCD’s Tax Partner Juan Rodríguez-Loras gives his opinion in Spanish newspaper ABC.
Latest news
Expansión, a Spanish economic and business newspaper, has published an interview with Adolf Rousaud, Managing Partner of RCD.
RCD – Rousaud Costas Duran has advised AlbaJuna Therapeutics, a spin-off from the IrsiCaixa AIDS Research Institute, on the investment of €3.75M by the pharmaceutical company Grifols, which will support the development of therapeutic antibodies to fight HIV. The amount invested is expected to increase as each molecule development stage is completed.
RCD reinforces its Administrative and Urban Planning Department with the incorporation of Enric Acero, formerly the Municipal Secretary of Parets del Vallès Town Council and Secretary of its Industrial Board.
Rousaud Costas Duran has been one of the most active firms in the transactional market throughout 2015, according to the most relevant rankings of the sector such as TTR (Transactional Track Record) or Bloomberg.